Tags

Type your tag names separated by a space and hit enter

Dyslipidemia and the risk of end stage renal disease.
J Med Liban. 2004 Jul-Sep; 52(3):156-9.JM

Authors+Show Affiliations

Haydar AA
Renal Medicine and Transplantation Department, Guy's Hospital, London, UK.
Goldsmith DJ
No affiliation info available

MeSH

Clinical Trials as TopicDisease ProgressionDyslipidemiasHumansHydroxymethylglutaryl-CoA Reductase InhibitorsKidney Failure, ChronicProteinuria

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16432973

Citation

Haydar, Ali A., and David J A. Goldsmith. "Dyslipidemia and the Risk of End Stage Renal Disease." Le Journal Medical Libanais. the Lebanese Medical Journal, vol. 52, no. 3, 2004, pp. 156-9.
Haydar AA, Goldsmith DJ. Dyslipidemia and the risk of end stage renal disease. J Med Liban. 2004;52(3):156-9.
Haydar, A. A., & Goldsmith, D. J. (2004). Dyslipidemia and the risk of end stage renal disease. Le Journal Medical Libanais. the Lebanese Medical Journal, 52(3), 156-9.
Haydar AA, Goldsmith DJ. Dyslipidemia and the Risk of End Stage Renal Disease. J Med Liban. 2004 Jul-Sep;52(3):156-9. PubMed PMID: 16432973.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dyslipidemia and the risk of end stage renal disease. AU - Haydar,Ali A, AU - Goldsmith,David J A, PY - 2006/1/26/pubmed PY - 2006/2/24/medline PY - 2006/1/26/entrez SP - 156 EP - 9 JF - Le Journal medical libanais. The Lebanese medical journal JO - J Med Liban VL - 52 IS - 3 SN - 0023-9852 UR - https://www.unboundmedicine.com/medline/citation/16432973/Dyslipidemia_and_the_risk_of_end_stage_renal_disease_ DB - PRIME DP - Unbound Medicine ER -